📄 South Carolina
Sign in

Back to


South Carolina


Biologics Compliance Guide for Clinics in South Carolina

Learn the essential compliance steps to confidently offer biologics in South Carolina. This guide covers state and FDA regulations, patient consent, and best practices to help you establish compliant stem cell therapy services.

1. Summary

Biologic treatments, including stem cell therapy, are governed by a combination of FDA and state-specific regulations. This guide provides an overview of compliance requirements for clinics in South Carolina, ensuring that providers meet both federal and state guidelines for safe and lawful practice.


2. FDA Compliance

Clinics must adhere to the FDA's guidelines for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Specifically, providers should understand the requirements under 21 CFR Part 1271, which outline registration, screening, and testing for safety and efficacy.


3. South Carolina State Regulations

To comply with South Carolina-specific regulations, clinics should refer to the South Carolina Department of Health and Environmental Control (DHEC) for current guidelines regarding biologics and advanced therapies. South Carolina may have unique protocols for clinical oversight or operational standards; thus, staying updated with these is crucial for compliance.


4. Provider Qualifications

In South Carolina, licensed medical doctors (MDs), doctors of osteopathy (DOs), and other practitioners under physician supervision qualify to administer biologic treatments, including stem cell therapy. For more details on specific licensure requirements, visit the South Carolina Board of Medical Examiners page.


5. Patient Informed Consent

Ensuring that patients provide informed consent is essential. Providers should clearly explain the benefits, potential risks, and experimental nature of stem cell treatments. South Carolina clinics should prepare consent forms that highlight:

  • The nature of the biologic therapy
  • Potential risks and side effects
  • Alternative treatment options
  • Disclaimers on experimental status if applicable


6. Pre-Treatment and Post-Treatment Protocols

Establishing clear pre-treatment and post-treatment protocols is recommended to ensure patient safety and adherence to best practices. This includes thorough patient screening, proper documentation, and follow-up care to monitor patient response.


7. Standard Operating Procedures (SOPs)

Clinics should implement SOPs for the collection, processing, storage, and administration of biologics. SOPs help standardize care, enhance safety, and maintain compliance with both state and federal regulations.


8. Medical Liability Insurance

Obtaining medical liability insurance is strongly advised to protect the clinic against potential malpractice claims. Verify that your insurance policy covers the specific scope of services offered in biologic therapy.


9. Marketing Compliance

All marketing materials should adhere to truthful advertising standards, avoiding any misleading claims. Ensure that any promotional content complies with both FDA advertising guidelines and South Carolina’s specific advertising regulations for medical services.

This guide is provided as an informational resource to help clinics and practitioners understand general compliance requirements for biologics in South Carolina. It is not intended to serve as legal advice or replace consultation with qualified legal professionals. Regulations may vary and are subject to change; clinics and practitioners should consult legal counsel or regulatory experts for advice specific to their circumstances and ensure full compliance with all applicable federal and state laws. The authors and publishers of this guide disclaim any liability arising from its use or reliance on the information provided.